Search Results - "Orr, W Shannon"

Refine Results
  1. 1
  2. 2

    Complete Remission of Metastatic Melanoma of the Scalp Following Treatment With Nivolumab Plus Relatlimab by McMinn, Mary E, Brister, Kelly A, Orr, W Shannon, Sheehan, Natale T, Christopher, Wade O

    Published in The American surgeon (01-08-2024)
    “…Melanoma is an aggressive malignancy accounting for approximately 1% of all skin cancers. The standard of care for distant melanoma of the skin is…”
    Get more information
    Journal Article
  3. 3
  4. 4

    Poorly Differentiated Metastatic Carcinoma of Possible Eccrine Sweat Gland Origin by Reyes, Gabriella, Grenn, Emily E, Orr, 3rd, W Shannon

    Published in The American surgeon (01-07-2022)
    “…Sweat gland carcinomas are a rare group of cancer, representing less than .01% of all diagnosed skin malignancies. We report the case of a 32-year-old male who…”
    Get more information
    Journal Article
  5. 5
  6. 6

    Expression of trefoil factor 3 is decreased in colorectal cancer by Espinoza, Ingrid, Agarwal, Sumit, Reddy, Amit, Shenoy, Veena, Subramony, Charulochana, Sakiyama, Marcelo, Fair, Logan, Poosarla, Teja, Zhou, Xinchun, Shannon Orr, W, Lahr, Christopher, Bae, Sejong, Al Diffalha, Sameer, Manne, Upender, Gomez, Christian R

    Published in Oncology reports (01-01-2021)
    “…In colorectal cancer (CRC), high expression of trefoil factor 3 (TFF3) is associated with tumor progression and reduced patient survival; however,…”
    Get full text
    Journal Article
  7. 7

    Analysis of Prognostic Factors in Extraosseous Ewing Sarcoma Family of Tumors: Review of St. Jude Children’s Research Hospital Experience by Shannon Orr, W., Denbo, Jason W., Billups, Catherine A., Wu, Jianrong, Navid, Fariba, Rao, Bhaskar N., Davidoff, Andrew M., Krasin, Matthew J.

    Published in Annals of surgical oncology (01-11-2012)
    “…Background Advances in the treatment of Ewing sarcoma family of tumors (ESFT) are the result of improvements in systemic and local therapies. Clinical data of…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Curcumin potentiates rhabdomyosarcoma radiosensitivity by suppressing NF-κB activity by Orr, W Shannon, Denbo, Jason W, Saab, Karim R, Ng, Catherine Y, Wu, Jianrong, Li, Kui, Garner, Jo Meagan, Morton, Christopher L, Du, Ziyun, Pfeffer, Lawrence M, Davidoff, Andrew M

    Published in PloS one (07-02-2013)
    “…Ionizing radiation (IR) is an essential component of therapy for alveolar rhabdomyosarcoma. Nuclear factor-kappaB (NF-κΒ) transcription factors are upregulated…”
    Get full text
    Journal Article
  11. 11

    Timing of Surgery and the Role of Adjuvant Radiotherapy in Ewing Sarcoma of the Chest Wall: A Single-institution Experience by Denbo, Jason W., Shannon Orr, W., Wu, Yanan, Wu, Jianrong, Billups, Catherine A., Navid, Fariba, Rao, Bhaskar N., Davidoff, Andrew M., Krasin, Matthew J.

    Published in Annals of surgical oncology (01-11-2012)
    “…Background Ewing sarcoma (ES) is the most common chest wall malignancy in adolescents. Current therapy incorporates chemotherapy to treat systemic disease and…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    HIF-1α activation mediates resistance to anti-angiogenic therapy in neuroblastoma xenografts by Hartwich, Joseph, Orr, W. Shannon, Ng, Catherine Y, Spence, Yunyu, Morton, Christopher, Davidoff, Andrew M

    Published in Journal of pediatric surgery (2013)
    “…Abstract Introduction The anti-tumor activity of angiogenesis inhibitors is often limited by the development of resistance to these drugs. Here we establish…”
    Get full text
    Journal Article
  15. 15

    Toward defining grade C pancreatic fistula following pancreaticoduodenectomy: incidence, risk factors, management and outcome by Denbo, Jason W, Orr, W. Shannon, Zarzaur, Ben L, Behrman, Stephen W

    Published in HPB (Oxford, England) (01-09-2012)
    “…Abstract Background In 2005 the International Study Group for Pancreatic Fistula (ISGPF) created a definition and grading system for pancreatic fistulae (PF)…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Rapamycin increases neuroblastoma xenograft and host stromal derived osteoprotegerin inhibiting osteolytic bone disease in a bone metastasis model by Hartwich, Joseph E, Orr, W. Shannon, Ng, Catherine Y, Spence, Yunyu, McLaughlin, Jillian M, Furman, Wayne L, McGregor, Lisa M, Davidoff, Andrew M

    Published in Journal of pediatric surgery (2013)
    “…Abstract Purpose Osteoprotegerin (OPG) is a decoy receptor for the Receptor of NF-κB (RANK) ligand that can inhibit osteoclastogenesis. Previous studies have…”
    Get full text
    Journal Article
  19. 19

    Rapamycin-induced tumor vasculature remodeling in rhabdomyosarcoma xenografts increases the effectiveness of adjuvant ionizing radiation by Myers, Adrianne L, Orr, W. Shannon, Denbo, Jason W, Ng, Catherine Y, Zhou, Junfang, Spence, Yunyu, Wu, Jianrong, Davidoff, Andrew M

    Published in Journal of pediatric surgery (2012)
    “…Abstract Purpose Rapamycin inhibits vascular endothelial growth factor expression. Vascular endothelial growth factor is a tumor-elaborated protein that…”
    Get full text
    Journal Article
  20. 20

    Liposome-encapsulated curcumin suppresses neuroblastoma growth through nuclear factor-kappa B inhibition by ORR, Wayne S, DENBO, Jason W, SAAB, Karim R, MYERS, Adrianne L, NG, Catherine Y, JUNFANG ZHOU, MORTON, Christopher L, PFEFFER, Lawrence M, DAVIDOFF, Andrew M

    Published in Surgery (01-05-2012)
    “…Nuclear factor-κB (NF-κB) has been implicated in tumor cell proliferation and survival and in tumor angiogenesis. We sought to evaluate the effects of…”
    Get full text
    Journal Article